<DOC>
	<DOCNO>NCT02243813</DOCNO>
	<brief_summary>The current protocol pilot study effect possible utility psilocybin-facilitated experience professional religious leader .</brief_summary>
	<brief_title>Effects Psilocybin-facilitated Experience Psychology Effectiveness Professional Leaders Religion</brief_title>
	<detailed_description />
	<mesh_term>Psilocybine</mesh_term>
	<criteria>Inclusion criterion : Have give write informed consent College graduation equivalent graduate/professional training . Recognized leadership position wellestablished religious organization ; professional activity must include significant time interact seek religious/spiritual guidance support . Be healthy psychologically stable determine screen medical psychiatric problem via personal interview , medical questionnaire , physical examination , electrocardiogram ( ECG ) , routine medical blood urinalysis laboratory test During next year foreseen likelihood major potentially lifealtering event close family member ( e.g . retirement major career change volunteer ; lifethreatening illness spouse child volunteer ) Agree consume approximately amount caffeinecontaining beverage ( e.g. , coffee , tea ) he/she consume usual morning , arrive research unit morning psilocybin session day . If participant routinely consume caffeinated beverage , he/she must agree session day . Agree refrain use psychoactive drug , include alcoholic beverage nicotine , 24 hour drug administration . The exception caffeine . Participants require either nonsmoker nondaily smoker . Agree take PRN medication morning drug session Agree take sildenafil ( ViagraÂ® ) , tadalafil , similar medication within 72 hour drug administration . Agree one week drug session , he/she refrain take nonprescription medication , nutritional supplement , herbal supplement except approve study investigator . Exceptions evaluate study investigator include acetaminophen , nonsteroidal antiinflammatory drug , common dos vitamin mineral . General medical exclusion criterion : Women pregnant ( indicated positive urine pregnancy test assess intake drug session ) nursing ; woman childbearing potential sexually active practice effective mean birth control . Cardiovascular condition : coronary artery disease , stroke , angina , uncontrolled hypertension , clinically significant ECG abnormality ( e.g. , symptomatic atrial fibrilation ) , TIA past year Epilepsy history seizure Insulindependent diabetes ; take oral hypoglycemic agent , history hypoglycemia Currently take psychoactive prescription medication regular ( e.g. , daily ) basis Currently take regular ( e.g. , daily ) basis medication primary centrallyacting pharmacological effect serotonin neuron medication MAO inhibitor . For individual intermittent PRN use medication , psilocybin session conduct least 5 halflives agent elapse last dose . More 20 % outside upper low range ideal body weight accord Metropolitan Life height weight table Psychiatric Current past history meeting DSM5 criterion Schizophrenia , Psychotic Disorder ( unless substanceinduced due medical condition ) , Bipolar I II Disorder Current past history within last 5 year meet DSM5 criterion alcohol substance use disorder ( exclude caffeine nicotine ) severe major depression Have first seconddegree relative Schizophrenia , Psychotic Disorder ( unless substance induce due medical condition ) , Bipolar I II Disorder Has psychiatric condition judge incompatible establishment rapport safe exposure psilocybin</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Psilocybin</keyword>
	<keyword>Pharmacologic Actions</keyword>
	<keyword>Psychotropic Drugs</keyword>
</DOC>